Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Christopher Goetz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Occupations

Neurology

Procedures

Anatomy

Adrenal Medulla

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ravina Bernard; Tanner Caroline; Dieuliis Diane; Eberly Shirley; Flagg Emily; Galpern Wendy R; Fahn Stanley; Goetz Christopher G; Grate Stephen; Kurlan Roger; Lang Anthony E; Marek Kenneth; Kieburtz Karl; Oakes David; Elliott Robin; Shoulson Ira;
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Goetz Christopher G
Jean-Martin Charcot and his vibratory chair for Parkinson disease.
Hinson Vanessa K; Goetz Christopher G; Leurgans Sue; Fan Wenqing; Nguyen Tiffany; Hsu Ann
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Christopher Goetz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ravina Bernard; Tanner Caroline; Dieuliis Diane; Eberly Shirley; Flagg Emily; Galpern Wendy R; Fahn Stanley; Goetz Christopher G; Grate Stephen; Kurlan Roger; Lang Anthony E; Marek Kenneth; Kieburtz Karl; Oakes David; Elliott Robin; Shoulson Ira;
A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(14):2081-90.
2009: Goetz Christopher G
Jean-Martin Charcot and his vibratory chair for Parkinson disease.
Neurology 2009;73(6):475-8.
2009: Hinson Vanessa K; Goetz Christopher G; Leurgans Sue; Fan Wenqing; Nguyen Tiffany; Hsu Ann
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Clinical neuropharmacology 2009;32(4):189-92.
2009: Goetz Christopher G; Nutt John G; Stebbins Glenn T; Chmura Teresa A
Teaching program for the Unified Dyskinesia Rating Scale.
Movement disorders : official journal of the Movement Disorder Society 2009;24(9):1296-8.
2009: Oken Barry S
The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies.
Neurology 2009;72(23):2053; author reply 2053-4.
2009: Diederich Nico J; Fénelon Gilles; Stebbins Glenn; Goetz Christopher G
Hallucinations in Parkinson disease.
Nature reviews. Neurology 2009;5(6):331-42.
2009: Bernard Bryan A; Stebbins Glenn T; Siegel Sandra; Schultz Theresa M; Hays Cynthia; Morrissey Mary J; Leurgans Sue; Goetz Christopher G
Determinants of quality of life in children with Gilles de la Tourette syndrome.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):1070-3.
2009: Barton Brandon; Zauber S Elizabeth; Goetz Christopher G
Movement disorders caused by medical disease.
Seminars in neurology 2009;29(2):97-110.
2009: Evatt Marian L; Chaudhuri K Ray; Chou Kelvin L; Cubo Ester; Hinson Vanessa; Kompoliti Katie; Yang Chengwu; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):635-46.
2009: Goetz Christopher G; Stebbins Glenn T; Wolff David; DeLeeuw William; Bronte-Stewart Helen; Elble Rodger; Hallett Mark; Nutt John; Ramig Lorraine; Sanger Terence; Wu Allan D; Kraus Peter H; Blasucci Lucia M; Shamim Ejaz A; Sethi Kapil D; Spielman Jennifer; Kubota Ken; Grove Andrew S; Dishman Eric; Taylor C Barr
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device.
Movement disorders : official journal of the Movement Disorder Society 2009;24(4):551-6.
2009: Olanow C Warren; Gracies Jean-Michel; Goetz Christopher G; Stoessl A Jon; Freeman Thomas; Kordower Jeffrey H; Godbold James; Obeso Jose A
Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
Movement disorders : official journal of the Movement Disorder Society 2009;24(3):336-43.
2008: Goetz Christopher G; Emre Murat; Dubois Bruno
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
Annals of neurology 2008;64 Suppl 2():S81-92.
2008: Goetz Christopher G; Nutt John G; Stebbins Glenn T
The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
Movement disorders : official journal of the Movement Disorder Society 2008;23(16):2398-403.
2008: Cubo Esther; Chmura Teresa; Goetz Christopher G
Comparison of tic characteristics between children and adults.
Movement disorders : official journal of the Movement Disorder Society 2008;23(16):2407-11.
2008: Goetz Christopher G; Tilley Barbara C; Shaftman Stephanie R; Stebbins Glenn T; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stern Matthew B; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; van Hilten Jacobus J; LaPelle Nancy;
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2129-70.
2008: Goldman Jennifer G; Goetz Christopher G; Brandabur Melanie; Sanfilippo Michelle; Stebbins Glenn T
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2248-50.
2008: Leentjens Albert F G; Dujardin Kathy; Marsh Laura; Martinez-Martin Pablo; Richard Irene H; Starkstein Sergio E; Weintraub Daniel; Sampaio Christina; Poewe Werner; Rascol Oliver; Stebbins Glenn T; Goetz Christopher G
Anxiety rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(14):2015-25.
2008: Leentjens Albert F G; Dujardin Kathy; Marsh Laura; Martinez-Martin Pablo; Richard Irene H; Starkstein Sergio E; Weintraub Daniel; Sampaio Cristina; Poewe Werner; Rascol Oliver; Stebbins Glenn T; Goetz Christopher G
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(14):2004-14.
2008: Louis E D; Broussolle E; Goetz C G; Krack P; Kaufmann P; Mazzoni P
Historical underpinnings of the term essential tremor in the late 19th century.
Neurology 2008;71(11):856-9.
2008: Diederich Nico J; Goetz Christopher G
The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
Neurology 2008;71(9):677-84.
2008: Goetz Christopher G; Fan Wenqing; Leurgans Sue
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
Movement disorders : official journal of the Movement Disorder Society 2008;23(11):1541-5.
2008: Goetz Christopher G; Leurgans Sue; Hinson Vanessa K; Blasucci Lucia M; Zimmerman Jennifer; Fan Wenqing; Nguyen Tiffany; Hsu Ann
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
Movement disorders : official journal of the Movement Disorder Society 2008;23(10):1479-82.
2008: Schwarzschild Michael A; Schwid Steven R; Marek Kenneth; Watts Arthur; Lang Anthony E; Oakes David; Shoulson Ira; Ascherio Alberto; Hyson Christopher; Gorbold Emily; Rudolph Alice; Kieburtz Karl; Fahn Stanley; Gauger Lisa; Goetz Christopher; Seibyl John; Forrest Misser; Ondrasik John
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Archives of neurology 2008;65(6):716-23.
2008: Diederich Nico J; Leurgans Sue; Fan Wenqing; Chmura Teresa A; Goetz Christopher G
Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies.
International journal of geriatric psychiatry 2008;23(6):598-603.
2008: Goetz Christopher G; Wuu Joanne; McDermott Michael P; Adler Charles H; Fahn Stanley; Freed Curt R; Hauser Robert A; Olanow Warren C; Shoulson Ira; Tandon P K; Leurgans Sue
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):690-9.
2008: Goetz Christopher G; Laska Eugene; Hicking Christine; Damier Philippe; Müller Thomas; Nutt John; Warren Olanow C; Rascol Olivier; Russ Hermann
Placebo influences on dyskinesia in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):700-7.
2008: Leehey M A; Berry-Kravis E; Goetz C G; Zhang L; Hall D A; Li L; Rice C D; Lara R; Cogswell J; Reynolds A; Gane L; Jacquemont S; Tassone F; Grigsby J; Hagerman R J; Hagerman P J
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
Neurology 2008;70(16 Pt 2):1397-402.
2008: Goetz Christopher G
Concerning about the accuracy of data reported.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):473; author reply 473.
2008: Fernandez Hubert H; Aarsland Dag; Fénelon Gilles; Friedman Joseph H; Marsh Laura; Tröster Alexander I; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):484-500.
2007: Dubois Bruno; Burn David; Goetz Christopher; Aarsland Dag; Brown Richard G; Broe Gerald A; Dickson Dennis; Duyckaerts Charles; Cummings Jefferey; Gauthier Serge; Korczyn Amos; Lees Andrew; Levy Richard; Litvan Irene; Mizuno Yoshikuni; McKeith Ian G; Olanow C Warren; Poewe Werner; Sampaio Cristina; Tolosa Eduardo; Emre Murat
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2314-24.
2007: Goetz Christopher G; Deuschl Guether
Disclosure on author work effort.
Movement disorders : official journal of the Movement Disorder Society 2007;22(14):1989.
2007: Emre Murat; Aarsland Dag; Brown Richard; Burn David J; Duyckaerts Charles; Mizuno Yoshikino; Broe Gerald Anthony; Cummings Jeffrey; Dickson Dennis W; Gauthier Serge; Goldman Jennifer; Goetz Christopher; Korczyn Amos; Lees Andrew; Levy Richard; Litvan Irene; McKeith Ian; Olanow Warren; Poewe Werner; Quinn Niall; Sampaio Christina; Tolosa Eduardo; Dubois Bruno
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(12):1689-707; quiz 1837.
2007: Goetz Christopher G
J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies.
Neurology 2007;69(1):103-9.
2007: Fabbrini Giovanni; Brotchie Jonathan M; Grandas Francisco; Nomoto Masahiro; Goetz Christopher G
Levodopa-induced dyskinesias.
Movement disorders : official journal of the Movement Disorder Society 2007;22(10):1379-89; quiz 1523.
2007: Schrag Anette; Barone Paolo; Brown Richard G; Leentjens Albert F G; McDonald William M; Starkstein Sergio; Weintraub Daniel; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Depression rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1077-92.
2007: Ravina Bernard; Marder Karen; Fernandez Hubert H; Friedman Joseph H; McDonald William; Murphy Diane; Aarsland Dag; Babcock Debra; Cummings Jefferey; Endicott Jean; Factor Stewart; Galpern Wendy; Lees Andrew; Marsh Laura; Stacy Mark; Gwinn-Hardy Katrina; Voon Valerie; Goetz Christopher
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1061-8.
2007: Litvan Irene; Chesselet Marie-Francoise; Gasser Thomas; Di Monte Donato A; Parker Davis; Hagg Theo; Hardy John; Jenner Peter; Myers Richard H; Price Donald; Hallett Mark; Langston William J; Lang Anthony E; Halliday Glenda; Rocca Walter; Duyckaerts Charles; Dickson Dennis W; Ben-Shlomo Yoav; Goetz Christopher G; Melamed Eldad
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.
Journal of neuropathology and experimental neurology 2007;66(5):329-36.
2007: Broussolle Emmanuel; Krack Paul; Thobois Stéphane; Xie-Brustolin Jing; Pollak Pierre; Goetz Christopher G
Contribution of Jules Froment to the study of parkinsonian rigidity.
Movement disorders : official journal of the Movement Disorder Society 2007;22(7):909-14.
2007: Litvan Irene; Halliday Glenda; Hallett Mark; Goetz Christopher G; Rocca Walter; Duyckaerts Charles; Ben-Shlomo Yoav; Dickson Dennis W; Lang Anthony E; Chesselet Marie-Francoise; Langston William J; Di Monte Donato A; Gasser Thomas; Hagg Theo; Hardy John; Jenner Peter; Melamed Eldad; Myers Richard H; Parker Davis; Price Donald L
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.
Journal of neuropathology and experimental neurology 2007;66(4):251-7.
2007: Goetz Christopher G; Deuschl Guenther
Author responsibilities and compliance with data source agreements.
Movement disorders : official journal of the Movement Disorder Society 2007;22(4):449.
2007: Lippa C F; Duda J E; Grossman M; Hurtig H I; Aarsland D; Boeve B F; Brooks D J; Dickson D W; Dubois B; Emre M; Fahn S; Farmer J M; Galasko D; Galvin J E; Goetz C G; Growdon J H; Gwinn-Hardy K A; Hardy J; Heutink P; Iwatsubo T; Kosaka K; Lee V M-Y; Leverenz J B; Masliah E; McKeith I G; Nussbaum R L; Olanow C W; Ravina B M; Singleton A B; Tanner C M; Trojanowski J Q; Wszolek Z K;
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Neurology 2007;68(11):812-9.
2007: Jasinska-Myga Barbara; Opala Grzegorz; Goetz Christopher G; Tustanowski Jerzy; Ochudlo Stanislaw; Gorzkowska Agnieszka; Tyrpa Jadwiga
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
Archives of neurology 2007;64(2):261-5.
2007: Berry-Kravis Elizabeth; Goetz Christopher G; Leehey Maureen A; Hagerman Randi J; Zhang Lin; Li Lexin; Nguyen Danh; Hall Deborah A; Tartaglia Nicole; Cogswell Jennifer; Tassone Flora; Hagerman Paul J
Neuropathic features in fragile X premutation carriers.
American journal of medical genetics. Part A 2007;143(1):19-26.
2007: Goetz Christopher G; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stebbins Glenn T; Stern Matthew B; Tilley Barbara C; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; Van Hilten Jacobus J; LaPelle Nancy
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):41-7.
2007: Goetz Christopher G; Damier Philippe; Hicking Christine; Laska Eugene; Müller Thomas; Olanow C Warren; Rascol Olivier; Russ Hermann
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):179-86.
2007: Goldman Jennifer G; Goetz Christopher G
History of Parkinson's disease.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():107-28.
2006: Friedman Joseph H; Berman Robert M; Goetz Christopher G; Factor Stewart A; Ondo William G; Wojcieszek Joanne; Carson William H; Marcus Ronald N
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2078-81.
2006: Goetz Christopher G; Vilensky Joel A
Early cinematographic studies of generalized dystonia.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1561-5.
2006: Elmer L; Schwid S; Eberly S; Goetz C; Fahn S; Kieburtz K; Oakes D; Blindauer K; Salzman P; Oren S; Prisco U L; Stern M; Shoulson I;
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
Journal of the neurological sciences 2006;248(1-2):78-83.
2006: Goetz Christopher G; Li John Michael; Wuu Joanne; Leurgans Sue
Does seasonal variation affect hallucinations in PD? A longitudinal study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(6):863-5.
2006: Goetz C G; Schwid S R; Eberly S W; Oakes D; Shoulson I;
Safety of rasagiline in elderly patients with Parkinson disease.
Neurology 2006;66(9):1427-9.
2006: Goetz Christopher G; Fan Wenqing; Leurgans Sue; Bernard Bryan; Stebbins Glenn T
The malignant course of "benign hallucinations" in Parkinson disease.
Archives of neurology 2006;63(5):713-6.
2006: Hinson Vanessa K; Weinstein Steven; Bernard Bryan; Leurgans Sue E; Goetz Christopher G
Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders.
Parkinsonism & related disorders 2006;12(3):177-80.
2006: Goetz Christopher G
Charcot in contemporary literature.
Journal of the history of the neurosciences 2006;15(1):22-30.
2006: Blindauer Karen; Shoulson Ira; Oakes David; Kieburtz Karl; Schwid Steven; Fahn Stanley; Stern Matthew; Goetz Christopher; Nutt John; Goren Sari; Sayag Naim; Scolnik Marisa; Levy Ruth; Eyal Eli; Salzman Phyllis; Pagano Mary;
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
Archives of neurology 2006;63(2):210-6.
2006: Goetz Christopher G; Wuu Joanne; Curgian Linda; Leurgans Sue
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2006;21(2):267-70.
2006: Kompoliti Katie; Goetz Christopher G; Morrissey Mary; Leurgans Sue
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects.
Movement disorders : official journal of the Movement Disorder Society 2006;21(2):248-52.
2006: Fénelon Gilles; Goetz Christopher G; Karenberg Axel
Hallucinations in Parkinson disease in the prelevodopa era.
Neurology 2006;66(1):93-8.
2006: Vilensky Joel A; Goetz Christopher G; Gilman Sid
Movement disorders associated with encephalitis lethargica: a video compilation.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):1-8.
2006: Goetz C G
What's new? Clinical progression and staging of Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(70):305-8.
2006: Kroonenberg Pieter M; Oort Frans J; Stebbins Glenn T; Leurgans Sue E; Cubo Esther; Goetz Christopher G
Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.
BMC medical research methodology 2006;6():26.
2005: McKeith I G; Dickson D W; Lowe J; Emre M; O'Brien J T; Feldman H; Cummings J; Duda J E; Lippa C; Perry E K; Aarsland D; Arai H; Ballard C G; Boeve B; Burn D J; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz C G; Gomez-Tortosa E; Halliday G; Hansen L A; Hardy J; Iwatsubo T; Kalaria R N; Kaufer D; Kenny R A; Korczyn A; Kosaka K; Lee V M Y; Lees A; Litvan I; Londos E; Lopez O L; Minoshima S; Mizuno Y; Molina J A; Mukaetova-Ladinska E B; Pasquier F; Perry R H; Schulz J B; Trojanowski J Q; Yamada M;
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology 2005;65(12):1863-72.
2005: Hinson Vanessa K; Cubo Esther; Comella Cynthia L; Goetz Christopher G; Leurgans Sue
Rating scale for psychogenic movement disorders: scale development and clinimetric testing.
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1592-7.
2005: Cubo Esther; Hinson Vanessa K; Goetz Christopher G; Garcia Ruiz Pedro; Garcia de Yebenes Justo; Marti María José; Rodriguez Oroz Maria Cruz; Linazasoro Gurutz; Chacón José; Vázquez Antonio; López del Val Javier; Leurgans Sue; Wuu Joanne
Transcultural comparison of psychogenic movement disorders.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1343-5.
2005: Goetz Christopher G; Poewe Werner; Rascol Olivier; Sampaio Cristina
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):523-39.
2005: Elm Jordan J; Goetz Christopher G; Ravina Bernard; Shannon Kathleen; Wooten George Fredrick; Tanner Caroline M; Palesch Yuko Y; Huang Peng; Guimaraes Paulo; Kamp Cornelia; Tilley Barbara C; Kieburtz Karl;
A responsive outcome for Parkinson's disease neuroprotection futility studies.
Annals of neurology 2005;57(2):197-203.
2005: Diederich Nico J; Goetz Christopher G; Stebbins Glenn T
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model.
Movement disorders : official journal of the Movement Disorder Society 2005;20(2):130-40.
2005: Goetz Christopher G; Wuu Joanne; Curgian Linda M; Leurgans Sue
Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.
Neurology 2005;64(1):81-6.
2005: Berry-Kravis Elizabeth; Potanos Kristina; Weinberg Dahlia; Zhou Lili; Goetz Christopher G
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.
Annals of neurology 2005;57(1):144-7.
2005: Goetz Christopher G
Movement disorders: understanding clinical trials.
Lancet neurology 2005;4(1):5-6.
2005: Guimaraes Paulo; Kieburtz Karl; Goetz Christopher G; Elm Jordan J; Palesch Yuko Y; Huang Peng; Ravina Bernard; Tanner Caroline M; Tilley Barbara C
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.
Clinical trials (London, England) 2005;2(6):509-18.
2004: Cubo Esther; Leurgans Sue; Goetz Christopher G
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.
Parkinsonism & related disorders 2004;10(8):507-10.
2004: Goetz Christopher G; Stebbins Glenn T
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1453-6.
2004: Stebbins G T; Goetz C G; Carrillo M C; Bangen K J; Turner D A; Glover G H; Gabrieli J D E
Altered cortical visual processing in PD with hallucinations: an fMRI study.
Neurology 2004;63(8):1409-16.
2004: Goetz Christopher G; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Counsell Carl; Giladi Nir; Holloway Robert G; Moore Charity G; Wenning Gregor K; Yahr Melvin D; Seidl Lisa;
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1020-8.
2004: Goldman Jennifer G; Goetz Christopher G; Berry-Kravis Elizabeth; Leurgans Sue; Zhou Lili
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
Archives of neurology 2004;61(8):1280-4.
2004: Barboi Alexandru C; Goetz Christopher G; Musetoiu Radu
The origins of scientific cinematography and early medical applications.
Neurology 2004;62(11):2082-6.
2004: Li Y J; Hauser M A; Scott W K; Martin E R; Booze M W; Qin X J; Walter J W; Nance M A; Hubble J P; Koller W C; Pahwa R; Stern M B; Hiner B C; Jankovic J; Goetz C G; Small G W; Mastaglia F; Haines J L; Pericak-Vance M A; Vance J M
Apolipoprotein E controls the risk and age at onset of Parkinson disease.
Neurology 2004;62(11):2005-9.
2004: Goetz Christopher G
Medical-legal issues in Charcot's neurologic career.
Neurology 2004;62(10):1827-33.
2004: Olanow C Warren; Damier Philippe; Goetz Christopher G; Mueller Thomas; Nutt John; Rascol Olivier; Serbanescu Alexandru; Deckers Frieda; Russ Hermann
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
Clinical neuropharmacology 2004;27(2):58-62.
2003: Goetz Christopher G; LeWitt Peter A; Weidenman Meredith
Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1455-8.
2003: Li Yi-Ju; Oliveira Sofia A; Xu Puting; Martin Eden R; Stenger Judith E; Scherzer Clemens R; Hauser Michael A; Scott William K; Small Gary W; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Mathew B; Hiner Bradley C; Jankovic Joseph; Goetz Christopher G; Mastaglia Frank; Middleton Lefkos T; Roses Allen D; Saunders Ann M; Schmechel Donald E; Gullans Steven R; Haines Jonathan L; Gilbert John R; Vance Jeffery M; Pericak-Vance Margaret A; Hulette Christine; Welsh-Bohmer Kathleen A
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.
Human molecular genetics 2003;12(24):3259-67.
2003: Pappert E J; Goetz C G; Louis E D; Blasucci L; Leurgans S
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.
Neurology 2003;61(7):936-40.
2003: Goetz Christopher G; Janko Kimberly; Blasucci Lucy; Jaglin Jean A
Impact of placebo assignment in clinical trials of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(10):1146-9.
2003: Cubo Esther; Moore Charity G; Leurgans Sue; Goetz Christopher G
Wheeled and standard walkers in Parkinson's disease patients with gait freezing.
Parkinsonism & related disorders 2003;10(1):9-14.
2003: Olanow C Warren; Goetz Christopher G; Kordower Jeffrey H; Stoessl A Jon; Sossi Vesna; Brin Mitchell F; Shannon Kathleen M; Nauert G Michael; Perl Daniel P; Godbold James; Freeman Thomas B
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Annals of neurology 2003;54(3):403-14.
2003: Oliveira Sofia A; Scott William K; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Lyons Kelly E; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Jankovic Joseph; Ondo William G; Allen Fred H; Scott Burton L; Goetz Christopher G; Small Gary W; Mastaglia Frank L; Stajich Jeffrey M; Zhang Fengyu; Booze Michael W; Reaves Joshua A; Middleton Lefkos T; Haines Jonathan L; Pericak-Vance Margaret A; Vance Jeffery M; Martin Eden R
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.
Archives of neurology 2003;60(7):975-80.
2003: Diederich Nico J; Pieri Vannina; Goetz Christopher G
Coping strategies for visual hallucinations in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(7):831-2.
2003: Goetz Christopher G
Pierre Marie: gifted intellect, poor timing and unchecked emotionality.
Journal of the history of the neurosciences 2003;12(2):154-66.
2003: Factor S A; Feustel P J; Friedman J H; Comella C L; Goetz C G; Kurlan R; Parsa M; Pfeiffer R;
Longitudinal outcome of Parkinson's disease patients with psychosis.
Neurology 2003;60(11):1756-61.
2003: Goetz C G
[Progressive supranuclear palsy]
Revue neurologique 2003;159(5 Pt 2):3S25-9.
2003: Oliveira Sofia A; Scott William K; Martin Eden R; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Ondo William G; Allen Fred H; Scott Burton L; Goetz Christopher G; Small Gary W; Mastaglia Frank; Stajich Jeffrey M; Zhang Fengyu; Booze Michael W; Winn Michelle P; Middleton Lefkos T; Haines Jonathan L; Pericak-Vance Margaret A; Vance Jeffery M
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
Annals of neurology 2003;53(5):624-9.
2003: Berry-Kravis Elizabeth; Lewin Foster; Wuu Joanne; Leehey Maureen; Hagerman Randi; Hagerman Paul; Goetz Christopher G
Tremor and ataxia in fragile X premutation carriers: blinded videotape study.
Annals of neurology 2003;53(5):616-23.
2003: Litvan Irene; Bhatia Kailash P; Burn David J; Goetz Christopher G; Lang Anthony E; McKeith Ian; Quinn Niall; Sethi Kapil D; Shults Cliff; Wenning Gregor K;
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
Movement disorders : official journal of the Movement Disorder Society 2003;18(5):467-86.
2003: Goetz Christopher G
The prefaces by Charcot: leitmotifs of an international career.
Neurology 2003;60(8):1333-40.
2003: Diederich Nico J; Moore Charity G; Leurgans Sue E; Chmura Teresa A; Goetz Christopher G
Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Archives of neurology 2003;60(4):529-33.
2003: van der Walt J M; Martin E R; Scott W K; Zhang F; Nance M A; Watts R L; Hubble J P; Haines J L; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Mastaglia F; Roses A D; Stajich J M; Booze M W; Fujiwara K; Gibson R A; Middleton L T; Scott B L; Pericak-Vance M A; Vance J M
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
Neurology 2003;60(7):1189-91.
2003: van der Walt Joelle M; Nicodemus Kristin K; Martin Eden R; Scott William K; Nance Martha A; Watts Ray L; Hubble Jean P; Haines Jonathan L; Koller William C; Lyons Kelly; Pahwa Rajesh; Stern Matthew B; Colcher Amy; Hiner Bradley C; Jankovic Joseph; Ondo William G; Allen Fred H; Goetz Christopher G; Small Gary W; Mastaglia Frank; Stajich Jeffrey M; McLaurin Adam C; Middleton Lefkos T; Scott Burton L; Schmechel Donald E; Pericak-Vance Margaret A; Vance Jeffery M
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.
American journal of human genetics 2003;72(4):804-11.
2003: Goetz Christopher G; Leurgans Sue; Lang Anthony E; Litvan Irene
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.
Neurology 2003;60(6):917-22.
2003: Goetz Christopher G; Chmura Teresa A; Lanska Douglas
Part 1: the history of 19th century neurology and the American Neurological Association.
Annals of neurology 2003;53 Suppl 4():S2-S26.
2003: Goetz Christopher G
Treatment of advanced Parkinson's disease: an evidence-based analysis.
Advances in neurology 2003;91():213-28.
2002: Goetz Christopher G
History of the extensor plantar response: Babinski and Chaddock signs.
Seminars in neurology 2002;22(4):391-8.
2002: Goetz Christopher G
Jean-Martin Charcot and the aging brain.
Archives of neurology 2002;59(11):1821-4.
2002: Diederich Nico J; Raman Rema; Leurgans Sue; Goetz Christopher G
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
Archives of neurology 2002;59(8):1249-52.
2002: Horn Stacy S; Goetz Christopher G
The election of Sarah McNutt as the first woman member of the American Neurological Association.
Neurology 2002;59(1):113-7.
2002: Rascol Olivier; Goetz Christopher; Koller William; Poewe Werner; Sampaio Cristina
Treatment interventions for Parkinson's disease: an evidence based assessment.
Lancet 2002;359(9317):1589-98.
2002: Goetz Christopher G; Hinson Vanessa K
Therapies for movement disorders.
Archives of neurology 2002;59(5):699-702.
2002: Kompoliti K; Adler C H; Raman R; Pincus J H; Leibowitz M T; Ferry J J; Blasucci L; Caviness J N; Leurgans S; Chase W M; Yones L C; Tan E; Carvey P; Goetz C G
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics.
Neurology 2002;58(9):1418-22.
2002: Li Yi-Ju; Scott William K; Hedges Dale J; Zhang Fengyu; Gaskell P Craig; Nance Martha A; Watts Ray L; Hubble Jean P; Koller William C; Pahwa Rajesh; Stern Matthew B; Hiner Bradley C; Jankovic Joseph; Allen Fred A; Goetz Christopher G; Mastaglia Frank; Stajich Jeffrey M; Gibson Rachel A; Middleton Lefkos T; Saunders Ann M; Scott Burton L; Small Gary W; Nicodemus Kristin K; Reed Allison D; Schmechel Donald E; Welsh-Bohmer Kathleen A; Conneally P Michael; Roses Allen D; Gilbert John R; Vance Jeffery M; Haines Jonathan L; Pericak-Vance Margaret A
Age at onset in two common neurodegenerative diseases is genetically controlled.
American journal of human genetics 2002;70(4):985-93.
2002: Goetz Christopher G; Leurgans Sue; Raman Rema;
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2002;17(2):283-8.
2002: Pramstaller P P; Künig G; Leenders K; Kann M; Hedrich K; Vieregge P; Goetz C G; Klein C
Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study.
Neurology 2002;58(5):808-10.
2002: Goetz Christopher G; Carvey Paul M; Pappert Eric J; Vu Toan Q; Leurgans Sue E
The role of the serotonin system in animal models of myoclonus.
Advances in neurology 2002;89():244-8.
2001: Goetz C G; Aminoff M J
The Brown-Séquard and S. Weir Mitchell letters.
Neurology 2001;57(11):2100-4.
2001: Goetz C G; Leurgans S; Pappert E J; Raman R; Stemer A B
Prospective longitudinal assessment of hallucinations in Parkinson's disease.
Neurology 2001;57(11):2078-82.
2001: Martin E R; Scott W K; Nance M A; Watts R L; Hubble J P; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Masterman D; Mastaglia F; Laing N G; Stajich J M; Ribble R C; Booze M W; Rogala A; Hauser M A; Zhang F; Gibson R A; Middleton L T; Roses A D; Haines J L; Scott B L; Pericak-Vance M A; Vance J M
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
JAMA : the journal of the American Medical Association 2001;286(18):2245-50.
2001: Scott W K; Nance M A; Watts R L; Hubble J P; Koller W C; Lyons K; Pahwa R; Stern M B; Colcher A; Hiner B C; Jankovic J; Ondo W G; Allen F H; Goetz C G; Small G W; Masterman D; Mastaglia F; Laing N G; Stajich J M; Slotterbeck B; Booze M W; Ribble R C; Rampersaud E; West S G; Gibson R A; Middleton L T; Roses A D; Haines J L; Scott B L; Vance J M; Pericak-Vance M A
Complete genomic screen in Parkinson disease: evidence for multiple genes.
JAMA : the journal of the American Medical Association 2001;286(18):2239-44.
2001: Kompoliti K; Goetz C G; Leurgans S; Raman R; Comella C L
Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome.
Neurology 2001;57(8):1519.
2001: Goetz C G; Chmura T A; Lanska D J
History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):954-9.
2001: Goetz C G; Chmura T A; Lanska D J
Medical art and photography in the history of movement disorders: Part 13 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):947-53.
2001: Goetz C G; Chmura T A; Lanska D J
Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden. Part 12 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):940-6.
2001: Cubo E; Gracies J M; Benabou R; Olanow C W; Raman R; Leurgans S; Goetz C G
Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
Archives of neurology 2001;58(9):1379-82.
2001: Goetz C G
Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease".
Neurology 2001;57(3):510-4.
2001: Lanska D J; Goetz C G; Chmura T A
Seminal figures in the History of Movement Disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):749-53.
2001: Lanska D J; Goetz C G; Chmura T A
Development of instruments for abnormal movements: postural sway and gait analyses. Part 10 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):742-8.
2001: Lanska D J; Goetz C G; Chmura T A
Development of instruments for abnormal movements: dynamometers, the dynamograph, and tremor recorders. Part 9 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):736-41.
2001: Goetz C G; Leurgans S; Chmura T A
Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):693-7.
2001: Kujawa K A; Niemi V R; Tomasi M A; Mayer N W; Cochran E; Goetz C G
Ballistic-choreic movements as the presenting feature of renal cancer.
Archives of neurology 2001;58(7):1133-5.
2001: Goetz C G; Chmura T A; Lanska D J
History of Myoclonus: Part 8 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):545-7.
2001: Goetz C G; Chmura T A; Lanska D J
Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):541.
2001: Goetz C G; Chmura T A; Lanska D J
Seminal figures in the history of movement disorders: Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of Movement Disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):537-40.
2001: Goetz C G
[History of dystonia]
Revue neurologique 2001;157(4):446-9.
2001: Goetz C G; Chmura T A; Lanska D J
History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):346-9.
2001: Goetz C G; Chmura T A; Lanska D J
History of dystonia: part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):339-45.
2001: Goetz C G; Chmura T A; Lanska D J
History of chorea: part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):331-8.
2001: Goetz C G; Horn S S
Treatment of tremor and dystonia.
Neurologic clinics 2001;19(1):129-44, vi-vii.
2001: Rascol O; Nutt J G; Blin O; Goetz C G; Trugman J M; Soubrouillard C; Carter J H; Currie L J; Fabre N; Thalamas C; Giardina W W; Wright S
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
Archives of neurology 2001;58(2):249-54.
2001: Goetz C G; Burke P F; Leurgans S; Berry-Kravis E; Blasucci L M; Raman R; Zhou L
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.
Archives of neurology 2001;58(2):209-13.
2001: Kompoliti K; Goetz C G; Vu T Q; Carvey P M; Leurgans S; Raman R
Estrogen supplementation in the posthypoxic myoclonus rat model.
Clinical neuropharmacology 2001;24(1):58-61.
2001: Louis E D; Barnes L; Wendt K J; Ford B; Sangiorgio M; Tabbal S; Lewis L; Kaufmann P; Moskowitz C; Comella C L; Goetz C C; Lang A E
A teaching videotape for the assessment of essential tremor.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):89-93.
2001: Goetz C G; Chmura T A; Lanska D J
The history of Parkinson's disease: part 2 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June, 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):156-61.
2001: Goetz C G; Chmura T A; Lanska D J
The basal ganglia: part 1 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June 2000.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):152-5.
2001: Leckman J F; Cohen D J; Goetz C G; Jankovic J
Tourette syndrome: pieces of the puzzle.
Advances in neurology 2001;85():369-90.
2001: Goetz C G; Kompoliti K
Rating scales and quantitative assessment of tics.
Advances in neurology 2001;85():31-42.
2000: Kompoliti K; Comella C L; Jaglin J A; Leurgans S; Raman R; Goetz C G
Menstrual-related changes in motoric function in women with Parkinson's disease.
Neurology 2000;55(10):1572-5.
2000: Cubo E; Goetz C G
Dystonia secondary to Sjögren-Larsson syndrome.
Neurology 2000;55(8):1236-7.
2000: Lanska D J; Goetz C G
Romberg's sign: development, adoption, and adaptation in the 19th century.
Neurology 2000;55(8):1201-6.
2000: Kujawa K; Leurgans S; Raman R; Blasucci L; Goetz C G
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Archives of neurology 2000;57(10):1461-3.
2000: Diederich N J; Alesch F; Goetz C G
Visual hallucinations induced by deep brain stimulation in Parkinson's disease.
Clinical neuropharmacology 2000;23(5):287-9.
2000: Goetz C G; Blasucci L M; Leurgans S; Pappert E J
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
Neurology 2000;55(6):789-94.
2000: Goetz C G; Meisel E
Biological neurotoxins.
Neurologic clinics 2000;18(3):719-40.
2000: Palfi S; Leventhal L; Goetz C G; Hantraye T; Roitberg B Z; Sramek J; Emborg M; Kordower J H
Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):524-30.
2000: Goetz C G; Stebbins G T; Blasucci L M
Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):479-84.
2000: Goetz C G
Battle of the titans: Charcot and Brown-Séquard on cerebral localization.
Neurology 2000;54(9):1840-7.
2000: Stebbins G T; Gabrieli J D; Shannon K M; Penn R D; Goetz C G
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease.
Brain and cognition 2000;42(3):348-63.
2000: Diederich N J; Pieri V; Goetz C G
[Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]
Fortschritte der Neurologie-Psychiatrie 2000;68(3):129-36.
2000: Kompoliti K; Goetz C G; Leurgans S; Morrissey M; Siegel I M
"On" freezing in Parkinson's disease: resistance to visual cue walking devices.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):309-12.
2000: Cubo E; Stebbins G T; Golbe L I; Nieves A; Leurgans S; Goetz C G; Kompoliti K
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):276-9.
2000: Diederich N J; Goetz C G
Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease.
Brain and cognition 2000;42(2):294-306.
2000: Goetz C G
William Osler: on Chorea: on Charcot.
Annals of neurology 2000;47(3):404-7.
2000: Sallee F R; Kurlan R; Goetz C G; Singer H; Scahill L; Law G; Dittman V M; Chappell P B
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.
Journal of the American Academy of Child and Adolescent Psychiatry 2000;39(3):292-9.
2000: Goetz C G
Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot.
Muscle & nerve 2000;23(3):336-43.
2000: Goetz C G; Leurgans S; Raman R; Stebbins G T
Objective changes in motor function during placebo treatment in PD.
Neurology 2000;54(3):710-4.
2000: Kompoliti K; Wang Q E; Goetz C G; Leurgans S; Raman R
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease.
Neurology 2000;54(2):458-62.
2000: Pieri V; Diederich N J; Raman R; Goetz C G
Decreased color discrimination and contrast sensitivity in Parkinson's disease.
Journal of the neurological sciences 2000;172(1):7-11.
2000: Goetz C G; Vu T Q; Carvey P M; Leurgans S
Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences.
Movement disorders : official journal of the Movement Disorder Society 2000;15 Suppl 1():39-46.
2000: Kompoliti K; Goetz C G
Therapeutic approaches.
Advances in neurology 2000;82():217-21.
2000: Goetz C G
Nineteenth century studies of atypical parkinsonism: Charcot and his Salpêtrière School.
Advances in neurology 2000;82():1-8.
1999: Kordower J H; Goetz C G
The first miracle in neurodegenerative disease: the discovery of oral levodopa.
Brain research bulletin 1999;50(5-6):377-8.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Scott W K; Yamaoka L H; Stajich J M; Scott B L; Vance J M; Roses A D; Pericak-Vance M A; Watts R L; Nance M; Hubble J; Koller W; Stern M B; Colcher A; Allen F H; Hiner B C; Jankovic J; Ondo W; Laing N G; Mastaglia F; Goetz C; Pappert E; Small G W; Masterman D; Haines J L; Davies T L
The alpha-synuclein gene is not a major risk factor in familial Parkinson disease.
Neurogenetics 1999;2(3):191-2.
1999: Freeman T B; Vawter D E; Leaverton P E; Godbold J H; Hauser R A; Goetz C G; Olanow C W
Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.
The New England journal of medicine 1999;341(13):988-92.
1999: Kompoliti K; Goetz C G; Gajdusek D C; Cubo E
Movement disorders in Kuru.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):800-4.
1999: Kordower J H; Palfi S; Chen E Y; Ma S Y; Sendera T; Cochran E J; Cochran E J; Mufson E J; Penn R; Goetz C G; Comella C D
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease.
Annals of neurology 1999;46(3):419-24.
1999: Barboi A C; Goetz C G
Parkinson's disease.
Clinical neuropharmacology 1999;22(4):184-91.
1999: Stebbins G T; Goetz C G; Lang A E; Cubo E
Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state.
Movement disorders : official journal of the Movement Disorder Society 1999;14(4):585-9.
1999: Goetz C G; Pappert E J; Louis E D; Raman R; Leurgans S
Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):502-6.
1999: Goetz C G
Charcot and the myth of misogyny.
Neurology 1999;52(8):1678-86.
1999: Stebbins G T; Gabrieli J D; Masciari F; Monti L; Goetz C G
Delayed recognition memory in Parkinson's disease: a role for working memory?
Neuropsychologia 1999;37(4):503-10.
1999: Goetz C G; Blasucci L; Stebbins G T
Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?
Neurology 1999;52(6):1227-9.
1999: Pappert E J; Goetz C G; Vu T Q; Ling Z D; Leurgans S; Raman R; Carvey P M
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists.
Neurology 1999;52(1):16-21.
1999: Bakdash T; Goetz C G; Singer H S; Cardoso F
A child with recurrent episodes of involuntary movements.
Movement disorders : official journal of the Movement Disorder Society 1999;14(1):146-54.
1999: Pappert E J; Goetz C G; Niederman F G; Raman R; Leurgans S
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(1):117-21.
1999: Goetz C G
Rating scales for dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():48-53.
1999: Goetz C G
Hallucinations in Parkinson's disease: the clinical syndrome.
Advances in neurology 1999;80():419-23.
1998: Diederich N J; Goetz C G; Raman R; Pappert E J; Leurgans S; Piery V
Poor visual discrimination and visual hallucinations in Parkinson's disease.
Clinical neuropharmacology 1998;21(5):289-95.
1998: Goetz C G; Vogel C; Tanner C M; Stebbins G T
Early dopaminergic drug-induced hallucinations in parkinsonian patients.
Neurology 1998;51(3):811-4.
1998: Kompoliti K; Goetz C G; Litvan I; Jellinger K; Verny M
Pharmacological therapy in progressive supranuclear palsy.
Archives of neurology 1998;55(8):1099-102.
1998: Kompoliti K; Goetz C G
Neuropharmacology in the elderly.
Neurologic clinics 1998;16(3):599-610.
1998: Stebbins G T; Goetz C G
Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):633-6.
1998: Litvan I; MacIntyre A; Goetz C G; Wenning G K; Jellinger K; Verny M; Bartko J J; Jankovic J; McKee A; Brandel J P; Chaudhuri K R; Lai E C; D'Olhaberriague L; Pearce R K; Agid Y
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.
Archives of neurology 1998;55(7):969-78.
1998: Kompoliti K; Goetz C G; Boeve B F; Maraganore D M; Ahlskog J E; Marsden C D; Bhatia K P; Greene P E; Przedborski S; Seal E C; Burns R S; Hauser R A; Gauger L L; Factor S A; Molho E S; Riley D E
Clinical presentation and pharmacological therapy in corticobasal degeneration.
Archives of neurology 1998;55(7):957-61.
1998: Buchman A S; Comella C L; Leurgans S; Stebbins G T; Goetz C G
The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD).
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):490-6.
1998: Kompoliti K; Goetz C G
Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):477-80.
1998: Goetz C G
Georges Guillain's neurologic exploration of America.
Neurology 1998;50(5):1451-5.
1998: Goetz C G
New lessons from old drugs: amantadine and Parkinson's disease.
Neurology 1998;50(5):1211-2.
1998: Goetz C G
Influence of COMT inhibition on levodopa pharmacology and therapy.
Neurology 1998;50(5 Suppl 5):S26-30.
1998: Goetz C G
Highlights of the North American and European experiences.
Neurology 1998;50(5 Suppl 5):S15-6.
1998: Pappert E J; Goetz C G; Stebbins G T; Belden M; Carvey P M
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes.
European journal of pharmacology 1998;347(1):51-6.
1998: Goetz C G; Pappert E J; Blasucci L M; Stebbins G T; Ling Z D; Nora M V; Carvey P M
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations.
Neurology 1998;50(2):515-7.
1998: Diederich N J; Goetz C G
Drug-induced movement disorders.
Neurologic clinics 1998;16(1):125-39.
1998: Litvan I; Booth V; Wenning G K; Bartko J J; Goetz C G; McKee A; Jankovic J; Jellinger K; Lai E C; Brandel J P; Verny M; Chaudhuri K R; Pearce R K; Agid Y
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(2-3):217-27.
1997: Bennett D A; Shannon K M; Beckett L A; Goetz C G; Wilson R S
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.
Neurology 1997;49(6):1580-7.
1997: Goetz C G
Eye signs and tic disorders: Gilles de la Tourette's syndrome.
Journal of the American Optometric Association 1997;68(11):688-92.
1997: Kompoliti K; Pappert E J; Goetz C G; Ford B; Wood N W
Progressive cognitive decline with truncal/limb ataxia and ballistic movements.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1075-84.
1997: Goetz C G; Stebbins G T; Blasucci L M; Grobman M S
Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1039-41.
1997: Watts R L; Subramanian T; Freeman A; Goetz C G; Penn R D; Stebbins G T; Kordower J H; Bakay R A
Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
Experimental neurology 1997;147(2):510-7.
1997: Litvan I; Goetz C G; Jankovic J; Wenning G K; Booth V; Bartko J J; McKee A; Jellinger K; Lai E C; Brandel J P; Verny M; Chaudhuri K R; Pearce R K; Agid Y
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.
Archives of neurology 1997;54(8):937-44.
1997: Pappert E J; Lipton J W; Goetz C G; Ling Z D; Stebbins G T; Carvey P M
The stability of carbidopa in solution.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):608-10.
1997: Comella C L; Stebbins G T; Goetz C G; Chmura T A; Bressman S B; Lang A E
Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale.
Movement disorders : official journal of the Movement Disorder Society 1997;12(4):570-5.
1997: Litvan I; Agid Y; Sastry N; Jankovic J; Wenning G K; Goetz C G; Verny M; Brandel J P; Jellinger K; Chaudhuri K R; McKee A; Lai E C; Pearce R K; Bartko J J;
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.
Neurology 1997;49(1):62-9.
1997: Freeman T B; Vawter D; Goetz C G; Leaverton P E; Hauser R A; Sanberg P R; Godbold J H; Olanow C W
Toward the use of surgical placebo-controlled trials.
Transplantation proceedings 1997;29(4):1925.
1997: Kordower J H; Freeman T B; Bakay R A; Goetz C G; Olanow C W
Treatment with fetal allografts.
Neurology 1997;48(6):1737-8.
1997: Kompoliti K; Goetz C G
Tourette syndrome. Clinical rating and quantitative assessment of tics.
Neurologic clinics 1997;15(2):239-54.
1997: Gabrieli J D; Stebbins G T; Singh J; Willingham D B; Goetz C G
Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning.
Neuropsychology 1997;11(2):272-81.
1997: Goetz C G
Jean-Martin Charcot and Silas Weir Mitchell.
Neurology 1997;48(4):1128-32.
1997: Kordower J H; Goetz C G; Freeman T B; Olanow C W
Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
Experimental neurology 1997;144(1):41-6.
1997: Goetz C G
New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists.
Experimental neurology 1997;144(1):17-20.
1997: Diederich N J; Comella C L; Goetz C G
[Botulin toxin: principles of action and neurological indications]
Presse médicale (Paris, France : 1983) 1997;26(2):96-100.
1997: Litvan I; Agid Y; Goetz C; Jankovic J; Wenning G K; Brandel J P; Lai E C; Verny M; Ray-Chaudhuri K; McKee A; Jellinger K; Pearce R K; Bartko J J
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.
Neurology 1997;48(1):119-25.
1996: Pappert E J; Goetz C G; Niederman F; Ling Z D; Stebbins G T; Carvey P M
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation.
Neurology 1996;47(6):1493-5.
1996: Goetz C G
An early photographic case of probable progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):617-8.
1996: Pappert E J; Tangney C C; Goetz C G; Ling Z D; Lipton J W; Stebbins G T; Carvey P M
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.
Neurology 1996;47(4):1037-42.
1996: Diederich N; Hilger C; Goetz C G; Keipes M; Hentges F; Vieregge P; Metz H
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
Annals of neurology 1996;40(3):463-5.
1996: Bonduelle M; Goetz C G
Charcot and aphasia.
Journal of the history of the neurosciences 1996;5(2):108-16.
1996: Goetz C G; Pappert E J
Early American professorships in neurology.
Annals of neurology 1996;40(2):258-63.
1996: Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin R C; Goetz C G; Golbe L I; Grafman J; Growdon J H; Hallett M; Jankovic J; Quinn N P; Tolosa E; Zee D S
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
1996: Fahn S; Brin M F; Dwork A J; Weiner W J; Goetz C G; Rajput A H
Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):298-310.
1996: Goetz C G; Diederich N J
There is a renaissance of interest in pallidotomy for Parkinson's disease.
Nature medicine 1996;2(5):510-4.
1996: Litvan I; Agid Y; Jankovic J; Goetz C; Brandel J P; Lai E C; Wenning G; D'Olhaberriague L; Verny M; Chaudhuri K R; McKee A; Jellinger K; Bartko J J; Mangone C A; Pearce R K
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Neurology 1996;46(4):922-30.
1996: Pappert E J; Buhrfiend C; Lipton J W; Carvey P M; Stebbins G T; Goetz C G
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use.
Movement disorders : official journal of the Movement Disorder Society 1996;11(1):24-6.
1996: Bennett D A; Beckett L A; Murray A M; Shannon K M; Goetz C G; Pilgrim D M; Evans D A
Prevalence of parkinsonian signs and associated mortality in a community population of older people.
The New England journal of medicine 1996;334(2):71-6.
1995: Goetz C G; Bonduelle M
Charcot as therapeutic interventionist and treating neurologist.
Neurology 1995;45(11):2102-6.
1995: Hubble J P; Koller W C; Cutler N R; Sramek J J; Friedman J; Goetz C; Ranhosky A; Korts D; Elvin A
Pramipexole in patients with early Parkinson's disease.
Clinical neuropharmacology 1995;18(4):338-47.
1995: Pappert E J; Goetz C G
Early American neurologic textbooks.
Neurology 1995;45(6):1228-32.
1995: McDermott M P; Jankovic J; Carter J; Fahn S; Gauthier S; Goetz C G; Golbe L I; Koller W; Lang A E; Olanow C W
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
1995: Goetz C G; Stebbins G T; Chmura T A; Fahn S; Klawans H L; Marsden C D
Teaching tape for the motor section of the unified Parkinson's disease rating scale.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):263-6.
1995: Goetz C G; Stebbins G T
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.
Neurology 1995;45(4):669-71.
1994: Comella C L; Goetz C G
Akathisia in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(5):545-9.
1994: Goetz C G; Stebbins G T; Shale H M; Lang A E; Chernik D A; Chmura T A; Ahlskog J E; Dorflinger E E
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):390-4.
1994: Goetz C G; Bolla K I; Rogers S M
Neurologic health outcomes and Agent Orange: Institute of Medicine report.
Neurology 1994;44(5):801-9.
1994: Goetz C G; Stebbins G T; Thelen J A
Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
Movement disorders : official journal of the Movement Disorder Society 1994;9(3):315-7.
1994: Comella C L; Stebbins G T; Brown-Toms N; Goetz C G
Physical therapy and Parkinson's disease: a controlled clinical trial.
Neurology 1994;44(3 Pt 1):376-8.
1994: Olanow C W; Marsden C D; Lang A E; Goetz C G
The role of surgery in Parkinson's disease management.
Neurology 1994;44(3 Suppl 1):S17-20.
1993: Goetz C G; Penn R D; Klawans H L
Fetal-tissue transplantation for Parkinson's disease.
The New England journal of medicine 1993;329(20):1498; author reply 1499-500.
1993: Goetz C G; Stebbins G T
Risk factors for nursing home placement in advanced Parkinson's disease.
Neurology 1993;43(11):2227-9.
1993: Kurth M C; Tetrud J W; Tanner C M; Irwin I; Stebbins G T; Goetz C G; Langston J W
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
Neurology 1993;43(9):1698-703.
1993: Buchman A S; Comella C L; Stebbins G T; Tanner C M; Goetz C G
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.
Clinical neuropharmacology 1993;16(3):205-10.
1993: Goetz C G; Thelen J A; MacLeod C M; Carvey P M; Bartley E A; Stebbins G T
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise.
Neurology 1993;43(5):1040-2.
1993: Carvey P M; Ptak L R; Nath S T; Sierens D K; Mufson E J; Goetz C G; Klawans H L
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.
Experimental neurology 1993;120(1):149-52.
1993: Goetz C G; De Long M R; Penn R D; Bakay R A
Neurosurgical horizons in Parkinson's disease.
Neurology 1993;43(1):1-7.
1993: Diederich N J; Goetz C G
[Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results]
Bulletin de la Société des sciences médicales du Grand-Duché de Luxembourg 1993;130(1):25-36.
1992: Wilson R S; Gilley D W; Tanner C M; Goetz C G
Ideational fluency in Parkinson's disease.
Brain and cognition 1992;20(2):236-44.
1992: Goetz C G; Pappert E J
Trauma and movement disorders.
Neurologic clinics 1992;10(4):907-19.
1992: Diederich N; Goetz C G; Stebbins G T; Klawans H L; Nittner K; Koulosakis A; Sanker P; Sturm V
Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease.
Neurology 1992;42(7):1311-4.
1992: Goetz C G; Diederich N J
Dopaminergic agonists in the treatment of Parkinson's disease.
Neurologic clinics 1992;10(2):527-40.
1992: Comella C L; Buchman A S; Tanner C M; Brown-Toms N C; Goetz C G
Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance.
Neurology 1992;42(4):878-82.
1992: Goetz C G; Tanner C M; Stebbins G T; Leipzig G; Carr W C
Adult tics in Gilles de la Tourette's syndrome: description and risk factors.
Neurology 1992;42(4):784-8.
1992: Langston J W; Widner H; Goetz C G; Brooks D; Fahn S; Freeman T; Watts R
Core assessment program for intracerebral transplantations (CAPIT).
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):2-13.
1992: Goetz C G
Clonidine and clonazepam in Tourette syndrome.
Advances in neurology 1992;58():245-51.
1991: Goetz C G; Stebbins G T; Klawans H L; Koller W C; Grossman R G; Bakay R A; Penn R D
United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up.
Neurology 1991;41(11):1719-22.
1991: Carvey P M; Ptak L R; Lo E S; Lin D H; Buhrfiend C M; Goetz C G; Klawans H L
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures.
Experimental neurology 1991;114(1):28-34.
1991: Koller W C; Block G A; Ahlskog J E; Ahrens S; Cedarbaum J M; Cyhan G; Goetz C G; LeWitt P A; Liss C; McLean L
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
Clinical neuropharmacology 1991;14(4):322-9.
1991: Carvey P M; McRae A; Lint T F; Ptak L R; Lo E S; Goetz C G; Klawans H L
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease.
Neurology 1991;41(5 Suppl 2):53-8; discussion 59-60.
1991: Goetz C G
Visual art in the neurologic career of Jean-Martin Charcot.
Archives of neurology 1991;48(4):421-5.
1991: Kordower J H; Cochran E; Penn R D; Goetz C G
Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.
Annals of neurology 1991;29(4):405-12.
1991: Shults C W; O'Connor D T; Baird A; Hill R; Goetz C G; Watts R L; Klawans H L; Carvey P M; Bakay R A; Gage F H
Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.
Experimental neurology 1991;111(3):276-81.
1991: Goetz C G; Stebbins G T
Effects of head trauma from motor vehicle accidents on Parkinson's disease.
Annals of neurology 1991;29(2):191-3.
1990: Olanow C W; Koller W; Goetz C G; Stebbins G T; Cahill D W; Gauger L L; Morantz R; Penn R D; Tanner C M; Klawans H L
Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results.
Archives of neurology 1990;47(12):1286-9.
1990: Diederich N; Goetz C G; Comella C L
New approaches in the treatment of the dystonias.
Klinische Wochenschrift 1990;68(19):935-41.
1990: Jankovic J; McDermott M; Carter J; Gauthier S; Goetz C; Golbe L; Huber S; Koller W; Olanow C; Shoulson I
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
Neurology 1990;40(10):1529-34.
1990: Goetz C G
Dopaminergic agonists in the treatment of Parkinson's disease.
Neurology 1990;40(10 Suppl 3):suppl 50-4; discussion 54-7.
1990: Goetz C G; Tanner C M; Penn R D; Stebbins G T; Gilley D W; Shannon K M; Klawans H L; Comella C L; Wilson R S; Witt T
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data.
Neurology 1990;40(2):273-6.
1990: Dietz M A; Goetz C G; Stebbins G T
Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes.
Movement disorders : official journal of the Movement Disorder Society 1990;5(3):243-7.
1990: Carvey P M; McRae A; Ptak L R; Kao L C; Lo E S; Goetz C G; Tanner C M; Penn R D; Klawans H L
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor.
Progress in brain research 1990;82():693-7.
1990: Goetz C G; Stebbins G T; Klawans H L; Koller W C; Grossman R G; Bakay R A; Penn R D
United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up.
Progress in brain research 1990;82():611-7.
1990: Goetz C G; Tanner C M
Gilles de la Tourette's syndrome in twins: clinical and neurochemical data.
Movement disorders : official journal of the Movement Disorder Society 1990;5(2):173-5.
1989: Goetz C G; Tanner C M; Gilley D W; Klawans H L
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
Neurology 1989;39(11 Suppl 2):63-6; discussion 72-3.
1989: Uitti R J; Tanner C M; Rajput A H; Goetz C G; Klawans H L; Thiessen B
Hypersexuality with antiparkinsonian therapy.
Clinical neuropharmacology 1989;12(5):375-83.
1989: Bennett D A; Ristanovic R K; Morrell F; Goetz C G
Dystonic posturing in temporal lobe seizures.
Neurology 1989;39(9):1270-2.
1989: Fox J H; Bennett D A; Goetz C G; Penn R D; Savoy S; Clasen R; Wilson R S
Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease.
Neurology 1989;39(9):1265.
1989: Goetz C G; Shannon K M; Tanner C M; Carroll V S; Klawans H L
Agonist substitution in advanced Parkinson's disease.
Neurology 1989;39(8):1121-2.
1989: Tanner C M; Chen B; Wang W; Peng M; Liu Z; Liang X; Kao L C; Gilley D W; Goetz C G; Schoenberg B S
Environmental factors and Parkinson's disease: a case-control study in China.
Neurology 1989;39(5):660-4.
1989: Goetz C G
[Where are the grafts in Parkinson's disease?]
La Revue du praticien 1989;39(8):675-7.
1989: Goetz C G; Olanow C W; Koller W C; Penn R D; Cahill D; Morantz R; Stebbins G; Tanner C M; Klawans H L; Shannon K M
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.
The New England journal of medicine 1989;320(6):337-41.
1988: Goetz C G; Tanner C M; Stebbins G T; Buchman A S
Risk factors for progression in Parkinson's disease.
Neurology 1988;38(12):1841-4.
1988: McRae-Degueurce A; Klawans H L; Penn R D; Dahlstrom A; Tanner C M; Goetz C G; Carvey P M
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.
Neuroscience letters 1988;94(1-2):192-7.
1988: Sprague S M; Corwin H L; Tanner C M; Wilson R S; Green B J; Goetz C G
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
Archives of internal medicine 1988;148(10):2169-72.
1988: Goetz C G
Shakespeare in Charcot's neurologic teaching.
Archives of neurology 1988;45(8):920-1.
1988: Goetz C G; Tanner C M; Shannon K M; Carroll V S; Klawans H L; Carvey P M; Gilley D
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations.
Neurology 1988;38(7):1143-6.
1988: Penn R D; Goetz C G; Tanner C M; Klawans H L; Shannon K M; Comella C L; Witt T R
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients.
Neurosurgery 1988;22(6 Pt 1):999-1004.
1988: Buchman A S; Goetz C G; Klawans H L
Hemiparkinsonism with hemiatrophy.
Neurology 1988;38(4):527-30.
1988: Goetz C G
The Salpêtrière in the wake of Charcot's death.
Archives of neurology 1988;45(4):444-7.
1988: Tanner C M; Wilson R S; Goetz C G; Shannon K M
The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia.
Advances in neurology 1988;50():557-60.
1988: Carvey P M; Hitri A; Goetz C G; Tanner C M; Klawans H L
Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
Life sciences 1988;42(22):2207-15.
1988: Goetz C G; Penn R D; Tanner C M
Efficacy of cervical cord stimulation in dystonia.
Advances in neurology 1988;50():645-9.
1988: Jankovic J; Armstrong D; Low N L; Goetz C G
Case 2, 1988. Congenital mental retardation and juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):352-61.
1988: Klawans H L; Tanner C M; Goetz C G
Epidemiology and pathophysiology of tardive dyskinesias.
Advances in neurology 1988;49():185-97.
1987: Shannon K M; Goetz C G; Carroll V S; Tanner C M; Klawans H L
Amantadine and motor fluctuations in chronic Parkinson's disease.
Clinical neuropharmacology 1987;10(6):522-6.
1987: Goetz C G; Tanner C M; Carroll V S; Shannon K M; Klawans H L
Controlled-release Sinemet.
Neurology 1987;37(9):1567-8.
1987: Goetz C G; Tanner C M; Wilson R S; Shannon K M
A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data.
Neurology 1987;37(9):1542-4.
1987: Goetz C G
Charcot at the Salpêtrière: ambulatory automatisms.
Neurology 1987;37(6):1084-8.
1987: Buchman A S; Bennett D A; Goetz C G
Bromocriptine-induced myoclonus.
Neurology 1987;37(5):885.
1987: Goetz C G; Tanner C M; Klawans H L; Shannon K M; Carroll V S
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet).
Neurology 1987;37(5):875-8.
1987: Goetz C G; Tanner C M; Shannon K M
Progression of Parkinson's disease without levodopa.
Neurology 1987;37(4):695-8.
1987: Goetz C G; Tanner C M; Wilson R S; Carroll V S; Como P G; Shannon K M
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
Annals of neurology 1987;21(3):307-10.
1987: Tanner C M; Goetz C G; Glantz R H; Klawans H L
Pergolide mesylate: four years experience in Parkinson's disease.
Advances in neurology 1987;45():547-9.
1987: Goetz C G; Wilson R S; Tanner C M; Garron D C
Relationships among pain, depression, and sleep alterations in Parkinson's disease.
Advances in neurology 1987;45():345-7.
1987: Goetz C G; Shannon K M; Carroll V S; Tanner C M; Weingarten R
The autonomic nervous system in Gilles de la Tourette's syndrome.
Movement disorders : official journal of the Movement Disorder Society 1987;2(2):99-102.
1986: Klawans H L; Carvey P M; Nelson D; Tanner C M; Goetz C G
The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
Life sciences 1986;38(19):1707-14.
1986: Carvey P M; Kao L C; Tanner C M; Goetz C G; Klawans H L
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity.
European journal of pharmacology 1986;120(2):193-9.
1986: Goetz C G; Lutge W; Tanner C M
Autonomic dysfunction in Parkinson's disease.
Neurology 1986;36(1):73-5.
1986: Goetz C G; Tanner C M; Levy M; Wilson R S; Garron D C
Pain in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):45-9.
1986: Carvey P; Paulseth J E; Goetz C G; Klawans H L
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update.
Advances in neurology 1986;43():509-17.
1986: Klawans H L; Carvey P M; Tanner C M; Goetz C G
Drug-induced myoclonus.
Advances in neurology 1986;43():251-64.
1986: Goetz C G
Charcot on Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):27-32.
1985: Tanner C M; Chhablani R; Goetz C G; Klawans H L
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease.
Neurology 1985;35(6):918-21.
1985: Goetz C G; Tanner C M; Glantz R H; Klawans H L
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Neurology 1985;35(5):749-51.
1985: Klawans H L; Carvey P; Tanner C M; Goetz C G
The pathophysiology of tardive dyskinesia.
The Journal of clinical psychiatry 1985;46(4 Pt 2):38-41.
1984: Goetz C G; Tanner C M; Klawans H L
Bupropion in Parkinson's disease.
Neurology 1984;34(8):1092-4.
1984: Goetz C G; Klawans H L
Tardive dyskinesia.
Neurologic clinics 1984;2(3):605-14.
1984: Goetz C G; Carvey P M; Tanner C M; Klawans H L
Neuroleptic-induced dopamine hyposensitivity.
Life sciences 1984;34(15):1475-9.
1984: Gerratt B R; Goetz C G; Fisher H B
Speech abnormalities in tardive dyskinesia.
Archives of neurology 1984;41(3):273-6.
1984: Goetz C G; Tanner C M; Klawans H L
Fluphenazine and multifocal tic disorders.
Archives of neurology 1984;41(3):271-2.
1984: Goetz C G; Tanner C M; Klawans H L
The pharmacology of olivopontocerebellar atrophy.
Advances in neurology 1984;41():143-8.
1984: Goetz C G
Sinemet skin rash.
Clinical neuropharmacology 1984;7(1):107-8.
1983: Goetz C G; Tanner C M; Glantz R; Klawans H L
Pergolide in Parkinson's disease.
Archives of neurology 1983;40(13):785-7.
1983: Goetz C G
Skin rash associated with Sinemet 25/100.
The New England journal of medicine 1983;309(22):1387-8.
1983: Goetz C G; Klawans H L
On the mechanism of sudden death in Moersch-Woltman syndrome.
Neurology 1983;33(7):930-2.
1983: Klawans H L; Goetz C G; Carvey P
Animal models of tardive dyskinesias.
Clinical neuropharmacology 1983;6(2):129-35.
1983: Goetz C G
Diagnosis of tardive dyskinesia.
Clinical neuropharmacology 1983;6(2):101-7.
1983: Goetz C G
Drug-induced Parkinsonism and idiopathic Parkinson's disease.
Archives of neurology 1983;40(5):325-6.
1983: Klawans H L; Goetz C G; Tanner C M; Nausieda P A; Weiner W J
Levodopa-free periods ("drug holidays") in the management of parkinsonism.
Advances in neurology 1983;37():33-43.
1983: Klawans H L; Tanner C M; Glatt S; Goetz C G
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease.
Advances in neurology 1983;37():75-83.
1983: Goetz C G; Klawans H L; Carvey P
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Modern problems of pharmacopsychiatry 1983;21():5-20.
1982: Goetz C G; Tanner C M; Klawans H L
Drug holiday in the management of Parkinson disease.
Clinical neuropharmacology 1982;5(4):351-64.
1982: Tanner C M; Goetz C G; Klawans H L
Cholinergic mechanisms in Tourette syndrome.
Neurology 1982;32(11):1315-7.
1982: Goetz C G
Coexisting tardive dyskinesia and parkinsonian symptoms.
The American journal of psychiatry 1982;139(11):1526-7.
1982: Tanner C M; Goetz C G; Glantz R H; Glatt S L; Klawans H L
Pergolide mesylate and idiopathic Parkinson disease.
Neurology 1982;32(10):1175-9.
1982: Glantz R; Weiner W J; Goetz C G; Nausieda P A; Klawans H L
Drug-induced asterixis in Parkinson disease.
Neurology 1982;32(5):553-5.
1982: Klawans H L; Stein R W; Tanner C M; Goetz C G
A pure parkinsonian syndrome following acute carbon monoxide intoxication.
Archives of neurology 1982;39(5):302-4.
1982: Goetz C G; Tanner C M; Klawans H L
Pharmacology of hallucinations induced by long-term drug therapy.
The American journal of psychiatry 1982;139(4):494-7.
1982: Klawans H L; Glantz R; Tanner C M; Goetz C G
Primary writing tremor: a selective action tremor.
Neurology 1982;32(2):203-6.
1982: Goetz C G
Pharmacology of animal neurotoxins.
Clinical neuropharmacology 1982;5(2):231-8.
1982: Goetz C G; Weiner W J; Nausieda P A; Klawans H L
Tardive dyskinesia: pharmacology and clinical implications.
Clinical neuropharmacology 1982;5(1):3-22.
1982: Goetz C G; Tanner C M; Klawans H L
Compressive neuropathies in Tourette syndrome.
Advances in neurology 1982;35():345-7.
1982: Weiner W J; Carvey P; Nausieda P A; Goetz C G; Klawans H L
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
Advances in neurology 1982;35():213-9.
1982: Goetz C G; Klawans H L
Gilles de la Tourette on Tourette syndrome.
Advances in neurology 1982;35():1-16.
1981: Goetz C G; Tanner C M; Nausieda P A
Weekly drug holiday in Parkinson disease.
Neurology 1981;31(11):1460-2.
1981: Goetz C G; Klawans H L
Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
Journal of clinical psychopharmacology 1981;1(5):297-303.
1981: Tanner C M; Goetz C G
CPK values in Parkinson's disease.
The New England journal of medicine 1981;304(26):1608-9.
1981: Weiner W J; Carvey P; Nausieda P A; Goetz C G; Klawans H L
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
Life sciences 1981;28(19):2173-8.
1981: Goetz C G; Nausieda P A; Weiner W J; Klawans H L
Practical guidelines for drug holidays in parkinsonian patients.
Neurology 1981;31(5):641-2.
1981: Koller W C; Weiner W J; Perlik S; Nausieda P A; Goetz C G; Klawans H L
Complications of chronic levodopa therapy: long-term efficacy of drug holiday.
Neurology 1981;31(4):473-6.
1981: Glantz R; Goetz C G; Nausieda P A; Weiner W J; Klawans H L
The effect of bromocriptine (BCT) on the on-off phenomenon.
Journal of neural transmission 1981;52(1-2):41-7.
1980: Tanner C; Goetz C G; Weiner W J
Anticholinergics and tardive dyskinesia.
The American journal of psychiatry 1980;137(11):1470-1.
1980: Goetz C G; Klawans H L
Gilles de la Tourette syndrome and compressive neuropathies.
Annals of neurology 1980;8(4):453.
1980: Klawans H L; Goetz C G; Perlik S
Presymptomatic and early detection in Huntington's disease.
Annals of neurology 1980;8(4):343-7.
1980: Goetz C G; Dysken M W; Klawans H L
Assessment and treatment of drug-induced tremor.
The Journal of clinical psychiatry 1980;41(9):310-5.
1980: Goetz C G
Defining drug-induced supersensitivity.
The American journal of psychiatry 1980;137(8):992-3.
1980: Klawans H L; Goetz C G; Perlik S
Tardive dyskinesia: review and update.
The American journal of psychiatry 1980;137(8):900-8.
1980: Klawans H L; Goetz C G; Paulson G W; Barbeau A
Levodopa and presymptomatic detection of Huntington's disease--eight-year follow-up.
The New England journal of medicine 1980;302(19):1090.
1979: Goetz C G; Klawans H L
Chronic agonist-induced hypersensitivity and on-off hyperkinesis.
Annals of neurology 1979;6(3):277-8.
1979: Weiner W J; Goetz C G; Nausieda P A; Klawans H L
Amphetamine-induced hypersensitivity in guinea pigs.
Neurology 1979;29(7):1054-7.
1979: Goetz C G; Weiner W J
Huntington's disease: current concepts of therapy.
Journal of the American Geriatrics Society 1979;27(1):23-6.
1978: Klawans H L; Goetz C G; Volkman P; Nausieda P A; Weiner W J
Lergotrile in the treatment of parkinsonism.
Neurology 1978;28(7):699-702.
1978: Weiner W J; Goetz C G; Nausieda P A; Klawans H L
Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea.
Annals of internal medicine 1978;88(3):327-31.
1974: Goetz C G; Klawans H L
Letter: Myoclonus, methysergide, and serotonin.
Lancet 1974;1(7869):1284-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Christopher Goetz

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Occupations

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Christopher Goetz (preview)

All Publications